FORTIS HEALTHCARE LTD. - 532843 - Outcome Of The Board Meeting And Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
The detailed disclosure is attached for your refrence.05-02-2021
05-02-2021
FORTIS HEALTHCARE LTD. - 532843 - Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
FORTIS HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, February 5, 2021 to, inter-alia, consider and approve un-audited financial results for the quarter ended December 31, 2020. Further, in continuation to our letter ref. FHL/SEC/2020-21 dated December 30, 2020 captioned 'Closure of Trading Window', it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till February 7, 2021. This is for your information and record please.29-01-2021
Today's Pick: Buy Fortis Healthcare (172.3)
Investors with a short-term perspective can buy the stock of Fortis Healthcare at current levels. The stock gained 4 per cent with above-average volu26-01-2021
FORTIS HEALTHCARE LTD. - 532843 - Shareholding for the Period Ended December 31, 2020
Fortis Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here15-01-2021
FORTIS HEALTHCARE LTD. - 532843 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- SUMIT GOELDesignation :- Company Secretary and Compliance Officer14-01-2021
Trading pick of the week: Fortis Healthcare (179.4): BUY
The stock of Fortis Healthcare jumped 9.5 per cent, accompanied by above average volume on Friday, conclusively breaking above a key long-term resista09-01-2021
FORTIS HEALTHCARE LTD. - 532843 - Intimation Of Trading Plan Under Regulation 5(5) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015
Please find enclosed Trading Plans dated January 8, 2021 received from Mr. Kapil Jain, Head Treasury (for proposed trading by his relative) and Mr. Anurag Kalra - Senior Vice President- Corporate Finance & Head- Investor Relations, of the Company under Regulation 5(5) of SEBI (Prohibition of Insider Trading) Regulations, 2015. This is for your information and records please.08-01-2021
Buy Fortis Healthcare; target of Rs 200: SPA Securities
SPA Securities is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 200 in its research report dated January 06, 2020.07-01-2021
FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Credit Rating
In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please note that ICRA Limited has upgraded: 1. the long-term rating for Line of Credit of SRL Limited, subsidiary, from [ICRA] A- (ICRA A minus) to [ICRA] A (ICRA A). The long-term rating of [ICRA]A (pronounced ICRA A) and short- term rating of [ICRA]A1 (pronounced ICRA A One) for the captioned LOC continue to be on watch with developing implications. 2. the long-term rating for Line of Credit of SRL Diagnostics Private Limited, step down subsidiary, from [ICRA] A- (ICRA A minus) to [ICRA] A (ICRA A). The long-term rating of [ICRA]A (pronounced ICRA A) and short- term rating of [ICRA]A1 (pronounced ICRA A One) for the captioned LOC continue to be on watch with developing implications. The detailed letters as issued by ICRA Limited are attached for your reference and records.30-12-2020
FORTIS HEALTHCARE LTD. - 532843 - Closure of Trading Window
With reference to the provisions of Policy / Code of Conduct for Prevention of Insider Trading, the "Trading Window" for dealing in shares of the Company is closed from December 31, 2020 till 48 hours of declaration of financial results for the quarter ending on December 31, 2020. This is for your information and records please.30-12-2020